TCG Crossover Management, LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1839948 PALO ALTO, CA

Back to AMLX Full portfolio

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$86,788,986

+$11,363,738 QoQ

Shares Held

6,243,812

0.0% QoQ

Ownership

5.62%

of shares outstanding

% of Portfolio

2.48%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

TCG Crossover Management, LLC holds $249,632,788 across 4 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (34.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc	11,020,968	$104,919,615
2	AMLX	Amylyx Pharmaceuticals, Inc. This page	6,243,812	$86,788,986
3	ADCT	ADC Therapeutics SA	11,390,175	$42,713,156
4	LQDA	Liquidia Corp	403,048	$15,211,031

All Filings in AMLX

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$86,788,986	6,243,812	0.0%	Shares	Sole	2026-05-15
2025-12-31	$75,425,248	6,243,812	0.0%	Shares	Sole	2026-02-17
2025-09-30	$84,853,405	6,243,812	+5.0%	Shares	Sole	2025-11-17
2025-06-30	$38,099,834	5,943,812	0.0%	Shares	Sole	2025-08-14
2025-03-31	$21,041,094	5,943,812	+28.0%	Shares	Sole	2025-05-14
2024-12-31	$17,553,609	4,643,812	0.0%	Shares	Sole	2025-02-14
2024-09-30	$15,045,950	4,643,812	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.